GENEVA (Reuters) - Smoking costs the global economy more than $1 trillion a year, and will kill one third more people by 2030 than it does now, according to a study by the World Health Organization and the U.S. National Cancer Institute published on Tuesday.
(Reuters) - Abbott Laboratories moved to protect patients with its St. Jude heart implants against possible cyber attacks, releasing a software patch on Monday that the firm said will reduce the "extremely low" chance of them being hacked.
(Reuters) - Regeneron Pharmaceuticals Chief Executive Len Schleifer on Monday ripped into Amgen Inc for its insistence on blocking sales of a rival Regeneron cholesterol drug while the appeals process in a patent infringement case plays out.
(Reuters) - The U.S. Food and Drug Administration on Monday approved Egalet Corp's long-acting opioid painkiller, Arymo ER, and will allow the company to claim it deters abuse by those seeking to dissolve and inject it.
CHICAGO (Reuters) - The U.S. Department of Agriculture said on Monday it had detected a type of bird flu in a wild duck in Montana that appeared to match one of the strains found during an outbreak of the disease in 2014 and 2015 that led to the deaths of millions of chickens.
(Reuters Health) - The number of older women in the U.S. being screened for breast cancer increased after the Affordable Care Act (ACA) became law in 2010 and free preventive healthcare was guaranteed, according to a new study.
(Reuters Health) - Widespread breast cancer screening may catch more small, slow-growing tumors that are unlikely to be fatal without curbing the diagnosis of advanced cancer cases, a Danish study suggests.
(Reuters Health) - An analysis of 15.3 million doctor office visits shows that physicians get paid significantly more if they are part of a large provider group, while insurance companies can dramatically reduce what they pay doctors for those visits if they've consolidated their share of the marketplace.
(Reuters Health) - Kids with behavioral problems may do better in school when they get to play virtual-reality games on stationary bikes instead of participating in traditional gym class activities, a small study suggests.
(Reuters) - Kite Pharma Inc said on Monday it partnered with Daiichi Sankyo Co Ltd to develop and commercialize its cancer treatment therapy in Japan, putting the U.S. company in line to receive up to $250 million in payments.
No comments:
Post a Comment